Gene Solutions
PrivateLast Round
Private Equity
Nov 18, 2025
Total Funding Raised
$36M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gene Solutions operates in Healthcare & Life Sciences and is based in Ho Chi Minh City. Its latest recorded funding round was a Strategic round in January 2025.
Gene Solutions is a biotechnology company that offers a comprehensive portfolio of advanced genetic testing solutions by integrating Next-Generation Sequencing (NGS) and Artificial Intelligence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Clinical Trials, Drug Discovery
Business Model
B2B2C
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gene Solutions Comparables
Compare Gene Solutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pathology Asia Holdings | 78% | |
| Natera, Inc. | 74% | |
| Nalagenetics | 71% |
For institutional investors. Book with your work email.
Gene Solutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Nov 18, 2025 | ||||
| Strategic | Jan 9, 2025 | ||||
| Series C | Apr 3, 2024 | ||||
| Series B Extension | Sep 20, 2023 | ||||
| Series B | Oct 5, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gene Solutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mekong Capital | Series B Extension, Series B |
| August Global Partners | Series C, Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 63% MoM, reaching 14.3K.
- Jan 7, 2026
Monthly visitors increased 144% to 10,000.
For institutional investors. Book with your work email.
Gene Solutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gene Solutions's valuation, stock price, and market status.
Is Gene Solutions a public or private company?
Gene Solutions is a private company.
What is the current stock price of Gene Solutions?
Gene Solutions is a private company, so its shares have no public market price. Caplight tracks Gene Solutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gene Solutions worth (valuation)?
Valuation information for Gene Solutions is not publicly available.
Can I buy Gene Solutions stock?
Gene Solutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gene Solutions's last funding round?
Gene Solutions's most recent funding round was Private Equity on November 18, 2025.
Who are the main investors in Gene Solutions?
Key investors in Gene Solutions include Mekong Capital, August Global Partners.
Will Gene Solutions IPO soon?
No public IPO plans have been announced for Gene Solutions.
How can I track Gene Solutions secondary market activity?
Caplight tracks bids, offers, and trades in Gene Solutions's shares on secondary markets.